Ltztherapeutics
Redwood City, US · Founded 2022 · 46 employees on LinkedIn · 1 known investors
Find your way into Ltztherapeutics
LTZ Therapeutics is an immunotherapy biotech developing treatments for oncology and autoimmune diseases using a myeloid cell engager approach centered on macrophages. It operates a Myeloid Engager Platform and has entered development collaborations with large pharmaceutical companies.
Founders & leadership
Ltztherapeutics was founded in 2022 by Robert Li.
RL
Robert LiinFounder, CEO
Investors · 1
Frequently asked questions
- What does Ltztherapeutics do?
- LTZ Therapeutics is an immunotherapy biotech developing treatments for oncology and autoimmune diseases using a myeloid cell engager approach centered on macrophages. It operates a Myeloid Engager Platform and has entered development collaborations with large pharmaceutical companies.
- Who founded Ltztherapeutics?
- Ltztherapeutics was founded by Robert Li in 2022.
- Who are Ltztherapeutics's investors?
- Ltztherapeutics's investors include Qiming Venture Partners.
- Where is Ltztherapeutics headquartered?
- Ltztherapeutics is headquartered in Redwood City, US.